Sourcing workspace
Profile updated 24 Oct 2026

Shilpa Pharma Lifesciences Limited

Also known as Shilpa Pharma · Shilpa Pharma Lifesciences Ltd. · Shilpa Pharma Lifesciences

ManufacturerLocations reported in Indiashilpapharma.com
AI visibility scorecardHow much can an AI assistant tell a buyer about Shilpa Pharma Lifesciences Limited?We scored this profile on the 8 questions buyers’ AI agents ask first, and ranked it against similar suppliers nearby.See the score

About

CDMO partner delivering end-to-end solutions across API oncology, generics, peptides, polymers and specialty chemicals.

Shilpa Pharma provides end-to-end pharmaceutical development and manufacturing, supporting clients from early development to commercial-scale manufacturing. Its stated areas of expertise include oncology APIs, formulations, peptides, polymers, and biologics.

Products

30 listed

SN-38

CAS No. 86639-52-3; DNA Topoisomerase I Inhibitor (Active metabolite of Irinotecan).

Source & evidence

Supplier website
SN-38 86639-52-3 DNA Topoisomerase I Inhibitor (Active metabolite of Irinotecan) Enquire Now
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Exatecan

CAS No. 171335-80-1; DNA Topoisomerase I Inhibitor (Camptothecin derivative).

Source & evidence

Supplier website
Exatecan 171335-80-1 DNA Topoisomerase I Inhibitor (Camptothecin derivative) Enquire Now
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

DM1

CAS No. 139504-50-0; Microtubule Inhibitor (Maytansinoid family).

Source & evidence

Supplier website
DM1 139504-50-0 Microtubule Inhibitor (Maytansinoid family) Enquire Now
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

DM4

CAS No. 796073-69-3; Microtubule Inhibitor (Maytansinoid family).

Source & evidence

Supplier website
DM4 796073-69-3 Microtubule Inhibitor (Maytansinoid family) Enquire Now
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

MMAE

CAS No. 474645-27-7; Microtubule Inhibitor (Auristatin family).

Source & evidence

Supplier website
MMAE 474645-27-7 Microtubule Inhibitor (Auristatin family) Enquire Now
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

MMAF

CAS No. 745017-94-1; Microtubule Inhibitor (Auristatin family).

Source & evidence

Supplier website
MMAF 745017-94-1 Microtubule Inhibitor (Auristatin family) Enquire Now
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Semaglutide

Peptide API manufactured by Shilpa Pharma.

Source & evidence

Supplier website
Shilpa Pharma manufactures a broad portfolio of peptide APIs across multiple therapeutic classes, including: GLP-1 / Metabolic Hormonal / Oncology Support Specialty / Other Semaglutide
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Octreotide Acetate

Peptide API manufactured by Shilpa Pharma.

Source & evidence

Supplier website
Shilpa Pharma manufactures a broad portfolio of peptide APIs across multiple therapeutic classes, including: GLP-1 / Metabolic Hormonal / Oncology Support Specialty / Other Semaglutide Octreotide Acetate
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Bivalirudin

Peptide API manufactured by Shilpa Pharma.

Source & evidence

Supplier website
Shilpa Pharma manufactures a broad portfolio of peptide APIs across multiple therapeutic classes, including: GLP-1 / Metabolic Hormonal / Oncology Support Specialty / Other Semaglutide Octreotide Acetate Bivalirudin
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Tirzepatide

Peptide API manufactured by Shilpa Pharma.

Source & evidence

Supplier website
Shilpa Pharma manufactures a broad portfolio of peptide APIs across multiple therapeutic classes, including: GLP-1 / Metabolic Hormonal / Oncology Support Specialty / Other Semaglutide Octreotide Acetate Bivalirudin Tirzepatide
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Leuprolide Acetate

Peptide API manufactured by Shilpa Pharma.

Source & evidence

Supplier website
Shilpa Pharma manufactures a broad portfolio of peptide APIs across multiple therapeutic classes, including: GLP-1 / Metabolic Hormonal / Oncology Support Specialty / Other Semaglutide Octreotide Acetate Bivalirudin Tirzepatide Leuprolide Acetate
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Desmopressin Acetate

Peptide API manufactured by Shilpa Pharma.

Source & evidence

Supplier website
Shilpa Pharma manufactures a broad portfolio of peptide APIs across multiple therapeutic classes, including: GLP-1 / Metabolic Hormonal / Oncology Support Specialty / Other Semaglutide Octreotide Acetate Bivalirudin Tirzepatide Leuprolide Acetate Desmopressin Acetate
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Liraglutide

Peptide API manufactured by Shilpa Pharma.

Source & evidence

Supplier website
Shilpa Pharma manufactures a broad portfolio of peptide APIs across multiple therapeutic classes, including: GLP-1 / Metabolic Hormonal / Oncology Support Specialty / Other Semaglutide Octreotide Acetate Bivalirudin Tirzepatide Leuprolide Acetate Desmopressin Acetate Liraglutide
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Goserelin Acetate

Peptide API manufactured by Shilpa Pharma.

Source & evidence

Supplier website
Shilpa Pharma manufactures a broad portfolio of peptide APIs across multiple therapeutic classes, including: GLP-1 / Metabolic Hormonal / Oncology Support Specialty / Other Semaglutide Octreotide Acetate Bivalirudin Tirzepatide Leuprolide Acetate Desmopressin Acetate Liraglutide Goserelin Acetate
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Teriparatide

Peptide API manufactured by Shilpa Pharma.

Source & evidence

Supplier website
Shilpa Pharma manufactures a broad portfolio of peptide APIs across multiple therapeutic classes, including: GLP-1 / Metabolic Hormonal / Oncology Support Specialty / Other Semaglutide Octreotide Acetate Bivalirudin Tirzepatide Leuprolide Acetate Desmopressin Acetate Liraglutide Goserelin Acetate Teriparatide
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Dulaglutide

Peptide API manufactured by Shilpa Pharma.

Source & evidence

Supplier website
Shilpa Pharma manufactures a broad portfolio of peptide APIs across multiple therapeutic classes, including: GLP-1 / Metabolic Hormonal / Oncology Support Specialty / Other Semaglutide Octreotide Acetate Bivalirudin Tirzepatide Leuprolide Acetate Desmopressin Acetate Liraglutide Goserelin Acetate Teriparatide Dulaglutide
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Lanreotide

Peptide API manufactured by Shilpa Pharma.

Source & evidence

Supplier website
Shilpa Pharma manufactures a broad portfolio of peptide APIs across multiple therapeutic classes, including: GLP-1 / Metabolic Hormonal / Oncology Support Specialty / Other Semaglutide Octreotide Acetate Bivalirudin Tirzepatide Leuprolide Acetate Desmopressin Acetate Liraglutide Goserelin Acetate Teriparatide Dulaglutide Lanreotide
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Glucagon

Peptide API manufactured by Shilpa Pharma.

Source & evidence

Supplier website
Shilpa Pharma manufactures a broad portfolio of peptide APIs across multiple therapeutic classes, including: GLP-1 / Metabolic Hormonal / Oncology Support Specialty / Other Semaglutide Octreotide Acetate Bivalirudin Tirzepatide Leuprolide Acetate Desmopressin Acetate Liraglutide Goserelin Acetate Teriparatide Dulaglutide Lanreotide Glucagon
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Exenatide

Peptide API manufactured by Shilpa Pharma.

Source & evidence

Supplier website
Shilpa Pharma manufactures a broad portfolio of peptide APIs across multiple therapeutic classes, including: GLP-1 / Metabolic Hormonal / Oncology Support Specialty / Other Semaglutide Octreotide Acetate Bivalirudin Tirzepatide Leuprolide Acetate Desmopressin Acetate Liraglutide Goserelin Acetate Teriparatide Dulaglutide Lanreotide Glucagon Exenatide
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Triptorelin

Peptide API manufactured by Shilpa Pharma.

Source & evidence

Supplier website
Shilpa Pharma manufactures a broad portfolio of peptide APIs across multiple therapeutic classes, including: GLP-1 / Metabolic Hormonal / Oncology Support Specialty / Other Semaglutide Octreotide Acetate Bivalirudin Tirzepatide Leuprolide Acetate Desmopressin Acetate Liraglutide Goserelin Acetate Teriparatide Dulaglutide Lanreotide Glucagon Exenatide Triptorelin
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Atosiban

Peptide API manufactured by Shilpa Pharma.

Source & evidence

Supplier website
Shilpa Pharma manufactures a broad portfolio of peptide APIs across multiple therapeutic classes, including: GLP-1 / Metabolic Hormonal / Oncology Support Specialty / Other Semaglutide Octreotide Acetate Bivalirudin Tirzepatide Leuprolide Acetate Desmopressin Acetate Liraglutide Goserelin Acetate Teriparatide Dulaglutide Lanreotide Glucagon Exenatide Triptorelin Atosiban
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Product categories

Locations & websites

3 locations · 1 website

Corporate Office

Shilpa Pharma Lifesciences Ltd. #12-6-214/A1, Shilpa house, Hyderabad Road, Raichur – 584 135, Karnataka State, India.

Raichur, India

Source & evidence

Supplier website
Corporate Office Address: Shilpa Pharma Lifesciences Ltd. #12-6-214/A1, Shilpa house, Hyderabad Road, Raichur – 584 135, Karnataka State, India.
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Supplier website
Corporate Office Address: Shilpa Pharma Lifesciences Ltd. #12-6-214/A1, Shilpa house, Hyderabad Road, Raichur – 584 135, Karnataka State, India.
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Supplier website
Corporate Office Address: Shilpa Pharma Lifesciences Ltd. #12-6-214/A1, Shilpa house, Hyderabad Road, Raichur – 584 135, Karnataka State, India.
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Supplier website
Corporate Office Address Shilpa Pharma Lifesciences Ltd. #12-6-214/A1, Shilpa house, Hyderabad Road, Raichur – 584 135, Karnataka State, India.
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Supplier website
Corporate Office Address: Shilpa Pharma Lifesciences Ltd. #12-6-214/A1, Shilpa house, Hyderabad Road, Raichur – 584 135, Karnataka State, India.
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Supplier website
Corporate Office Address: Shilpa Pharma Lifesciences Ltd. #12-6-214/A1, Shilpa house, Hyderabad Road, Raichur – 584 135, Karnataka State, India.
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Supplier website
Corporate Office Address: Shilpa Pharma Lifesciences Ltd. #12-6-214/A1, Shilpa house, Hyderabad Road, Raichur – 584 135, Karnataka State, India.
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Manufacturing Site

Shilpa Pharma Lifesciences Limited 100% Export Oriented Unit. Plot #33, 33A & 40 to 47, Raichur Growth Centre, Chicksugur Village, Raichur – 584134, Karnataka State, India.

Raichur, India

Source & evidence

Supplier website
Manufacturing Site Address: Shilpa Pharma Lifesciences Limited 100% Export Oriented Unit. Plot #33, 33A & 40 to 47, Raichur Growth Centre, Chicksugur Village, Raichur – 584134, Karnataka State, India.
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Supplier website
Manufacturing Site Address: Shilpa Pharma Lifesciences Limited 100% Export Oriented Unit. Plot #33, 33A & 40 to 47, Raichur Growth Centre, Chicksugur Village, Raichur – 584134, Karnataka State, India.
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Supplier website
Manufacturing Site Address: Shilpa Pharma Lifesciences Limited 100% Export Oriented Unit. Plot #33, 33A & 40 to 47, Raichur Growth Centre, Chicksugur Village, Raichur – 584134, Karnataka State, India.
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Supplier website
Manufacturing Site Address Shilpa Pharma Lifesciences Limited 100% Export Oriented Unit. Plot #33, 33A & 40 to 47, Raichur Growth Centre, Chicksugur Village, Raichur – 584134, Karnataka State, India.
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Supplier website
Manufacturing Site Address: Shilpa Pharma Lifesciences Limited 100% Export Oriented Unit. Plot #33, 33A & 40 to 47, Raichur Growth Centre, Chicksugur Village, Raichur – 584134, Karnataka State, India.
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Supplier website
Manufacturing Site Address: Shilpa Pharma Lifesciences Limited 100% Export Oriented Unit. Plot #33, 33A & 40 to 47, Raichur Growth Centre, Chicksugur Village, Raichur – 584134, Karnataka State, India.
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Supplier website
Manufacturing Site Address: Shilpa Pharma Lifesciences Limited 100% Export Oriented Unit. Plot #33, 33A & 40 to 47, Raichur Growth Centre, Chicksugur Village, Raichur – 584134, Karnataka State, India.
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Trade-fair listing
India
electronica 2026 exhibitor directory
Checked 26 Sept 2026

Trade-fair listing
electronica 2026 exhibitor directory
Checked 26 Sept 2026

Trade-fair listing
electronica 2026 exhibitor directory
Checked 26 Sept 2026

Reported location

Street address not provided.

Source & evidence

Supplier website
Offering CDMO Services from Discovery to Commercialization +91-9686397127 info@shilpapharma.com
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Supplier website
info@shilpapharma.com whatsapp us: +91 968 639 7127
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Supplier website
Offering CDMO Services from Discovery to Commercialization +91-9686397127 info@shilpapharma.com
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Supplier website
Offering CDMO Services from Discovery to Commercialization +91-9686397127 info@shilpapharma.com
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Supplier website
Offering CDMO Services from Discovery to Commercialization +91-9686397127 info@shilpapharma.com
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Company websites

Key capabilities

CapabilityDocumented scopeSupporting source
Advanced Peptide Modification and Conjugation ChemistryModifications include lipidation, PEGylation, cyclization, disulfide bridging, stapling, N-methylation, non-canonical amino acid incorporation, amidation, conjugation, labeling, phosphorylation, glycosylation, and macrocyclization.
Source & evidence

Supplier website
Lipidation / fatty-acid acylation (half-life extension) PEGylation (linear & branched) Head-to-tail & side-chain cyclization Selective / regioselective disulfide bridging Stapled peptides N-methylation & backbone modification Non-canonical / unnatural amino acid incorporation C-terminal amidation Peptide–drug conjugation (PDC) Phosphorylation & glycosylation Fluorescent labeling & biotinylation Chelator conjugation (e.g., DOTA) Multi-disulfide folding Macrocyclization
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Peptide Process DevelopmentSequence feasibility and synthesis strategy selection; resin, linker, and protecting-group optimization; process optimization; impurity profiling; salt-form selection; lyophilization development; and technology transfer to GMP.
Source & evidence

Supplier website
Key services include: Sequence feasibility analysis and synthesis strategy selection (SPPS vs. LPPS vs. hybrid) Resin, linker, and protecting-group strategy optimization (Fmoc / Boc) Fragment-condensation design for long and complex peptides Process optimization using DoE and Quality-by-Design (QbD) Peptide-related impurity profiling and control strategy (deletion, truncated, insertion sequences, D-isomers, aggregation) Counter-ion exchange and salt-form selection (acetate, hydrochloride, TFA removal) Lyophilization cycle development and solid-state characterization Technology transfer from research to GMP
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Analytical Method Development & ValidationDevelops HPLC and GC methods and validates analytical methods for raw materials, intermediates and APIs; also develops and validates methods for detoxification and decomposition analysis of oncology APIs.
Source & evidence

Supplier website
Analytical Method Development & Validation - as per ICH /ANVISA HPLC & GC Develop analytical methods using HPLC and GC for raw materials, intermediates, and NCE/API characterization. Detoxification Studies Develop and validate methods for detoxification and decomposition analysis of oncology APIs ensuring accuracy and reliability. Method Validation Validate analytical methods as per ICH and ANVISA guidelines for raw materials, intermediates, and APIs.
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Regulatory Documentation and Filing SupportSupport includes US FDA DMF preparation and filing, European EDMF and CEP applications, Japanese JDMF support, IMPD preparation, CTD dossier compilation, and responses to deficiency letters.
Source & evidence

Supplier website
US FDA Drug Master File (DMF) preparation and filing European Drug Master File (EDMF) and Certificate of Suitability (CEP) applications Japanese Drug Master File (JDMF) support IMPD (Investigational Medicinal Product Dossier) preparation CTD-format technical dossier compilation Regulatory response support for deficiency letters
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Analytical TestingQuality control testing for raw materials, intermediates and APIs, plus specification and testing procedure support, thermal analysis, particle size analysis and ion-chromatography analysis.
Source & evidence

Supplier website
Quality control testing (Assay, Related substances, Residual solvents, Wet chemical analysis, etc.) for Raw materials, Intermediates and APIs as per customer specification › Quality control testing as per compendial monograph specification › Proposal, review and finalization of Specification along with Standard Testing Procedure (STP) › Thermal analysis › Particle size analysis › Ion-Chromatography analysis
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Analytical and quality control servicesAnalytical testing and quality control including impurity profiling, structural and solid-state characterization, microbiology testing and stability studies.
Source & evidence

Supplier website
Our QC capabilities include: Chromatographic Analysis: HPLC, UPLC, GC, and LC-MS for precise impurity profiling and quality testing Structural & Solid-State Characterization: XRD, DSC, and spectroscopy for in-depth material analysis Microbiology & Contamination Control: Dedicated microbiology labs for sterility and bioburden testing Environmental Control: Clean rooms with HEPA filters ensuring contamination-free production Stability Studies: ICH-compliant stability chambers for long-term and accelerated stability testing
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Photo-Stability & Forced Degradation StudyStudies degradation pathways and mechanisms, the stability-indicating nature of methods, and chemical properties of drug molecules under ICH conditions.
Source & evidence

Supplier website
Forced degradation studies to showcase the specificity of stability indicating methods and gather essential data for determination of proper storage conditions, packaging and shelf life of product, which are vital for regulatory documentation Establishing degradation pathways of drug substances Revealing degradation mechanisms such as hydrolysis, oxidation, thermolysis or photolysis Establishing degradation pathways of drug substances Establishing the stability-indicating nature of a developed method Understanding the chemical properties of drug molecules Creating a degradation profile similar to formal stability studies under ICH conditions
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Impurity Evaluation & Impurity ProfilingIncludes identification of unknown impurities by LCMS and GCMS and quantification of nitrosamine, non-carryover, genotoxic and elemental impurities.
Source & evidence

Supplier website
Unknown impurities identification by mass spectroscopy - LCMS & GCMS Nitrosamine impurities quantifications Non-carryover impurities quantifications Genotoxic impurities quantifications Elemental Impurities quantifications (ICP-OES/MS) – as per ICH Q3D
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

ADC payload development supportSupport includes process optimization, analytical characterization, solid-state engineering, scalable manufacturing, and secure global shipment.
Source & evidence

Supplier website
As a trusted partner for ADC payload development and bulk supply, we provide complete support — from process optimization, analytical characterization, and solid-state engineering to scalable manufacturing and secure global shipment.
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Peptide CDMOEnd-to-end peptide development and manufacturing, from building blocks to final API, with peptide purification and lyophilization capabilities.
Source & evidence

Supplier website
End-to-end peptide development and manufacturing - from building blocks to final API Our specialized infrastructure for high-purity peptide synthesis, peptide purification and lyophilization capabilities include:
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Polymorph ProfilingEvaluates and identifies polymorphs, screens and qualifies polymorphic forms, and quantifies and establishes polymorphic nature in NCE/API.
Source & evidence

Supplier website
Evaluation & Identification of Polymorphs Systematic analysis of solid-state forms to identify potential polymorphs and assess stability characteristics. 2 Polymorph Screening & Qualification in NCE/API Comprehensive screening and qualification of polymorphic forms to ensure optimal characteristics for NCE/API development. 3 Quantification & Establishment of Polymorphic Nature Advanced analytical techniques used to quantify and establish the polymorphic nature in NCE/API formulations.
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Peptide Synthesis TechnologiesSolid-phase, solution/liquid-phase, hybrid SPPS–LPPS, recombinant/fermentation, and native chemical ligation synthesis routes.
Source & evidence

Supplier website
We offer solid-phase peptide synthesis (SPPS, both Fmoc and Boc strategies), solution/liquid-phase synthesis (LPPS), hybrid SPPS–LPPS for long and complex peptides, recombinant/fermentation-based routes, and native chemical ligation.
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Analytical development and process optimizationPayload classes are supported by analytical development, impurity profiling, stability assessment, and process optimization.
Source & evidence

Supplier website
Each payload class is supported by comprehensive analytical development, impurity profiling, stability assessment, and process optimization, ensuring consistent quality and reliable bulk supply.
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Pharmaceutical manufacturingDevelopment and delivery of NCEs across clinical phases, and supply of KSMs, RSMs, advanced intermediates and final APIs.
Source & evidence

Supplier website
Our state-of-the-art infrastructure enables us to meticulously design and execute the development and delivery of New Chemical Entities (NCEs) across all clinical phases. With a proven track record of successful regulatory audits, we are prepared to collaborate with our partners at any stage. Leveraging our expertise and strong analytical support, Shilpa pharma ensure seamless delivery of KSMs, RSMs, advanced intermediates, and final APIs, while avoiding supply chain hurdles and uncompromising on quality and timelines.
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Process safetyAssessment of hazards and risks, development of controls, and evaluation of process conditions for plant-scale safety.
Source & evidence

Supplier website
At Shilpa, our team will introspect the robustness of a developed route by identifying hazards, managing risks at an early stage, developing controls, evaluating and revising the conditions to make it safer and viable at plant scale.
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Custom ADC payload co-development and manufacturingCo-development and bulk manufacturing of novel or client-specific small-molecule warheads tailored to ADC constructs.
Source & evidence

Supplier website
Proprietary & Custom Payloads: Co-development and bulk manufacturing of novel or client-specific small-molecule warheads tailored to unique ADC constructs.
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

ADC payload manufacturing and bulk supplySpecialized large-scale ADC payload manufacturing and bulk production for pharmaceutical and biotech innovators.
Source & evidence

Supplier website
Shilpa Pharma is a world-class CDMO offering specialized, large-scale ADC payload manufacturing in India, focused exclusively on bulk production for global pharmaceutical and biotech innovators.
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Cleaning MethodDevelops cleaning methods for intermediates and APIs to support residue removal and regulatory compliance.
Source & evidence

Supplier website
Cleaning Method Develop effective cleaning methods for intermediates and APIs ensuring residue removal and regulatory compliance.
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Structure ElucidationUses NMR, mass spectrometry, IR and UV-Visible spectroscopy to identify and confirm chemical structures.
Source & evidence

Supplier website
At Shilpa Pharma, we use a range of advanced spectroscopic techniques—including NMR, mass spectrometry, IR, and UV-Visible spectroscopy—to accurately identify and confirm chemical structures.
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Route scouting, process development, scale-up, and commercial supplyIntegrated support from route scouting and process development through scale-up and commercial supply.
Source & evidence

Supplier website
Shilpa Pharma Lifesciences supports 10+ active NCE programs, providing integrated services from route scouting and process development to scale-up and commercial supply.
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Stability StudiesStability storage studies include refrigerated, accelerated, intermediate and long-term conditions.
Source & evidence

Supplier website
Stability Studies -20°C refrigerated storage 2°C to 8°C refrigerated storage 40°C/75%RH: Accelerated stability storage 30°C/65%RH: Intermediate stability storage 25°C/60%RH: Long term stability storage
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Biologics manufacturingBiologics services include monoclonal antibodies, biosimilars, peptides, and recombinant proteins.
Source & evidence

Supplier website
Yes, our CDMO biologics services include monoclonal antibodies, biosimilars, peptides, and recombinant proteins.
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Formulation developmentFormulation development for tablets, capsules, injectables, and advanced drug delivery systems.
Source & evidence

Supplier website
Our team specializes in CDMO formulation development for tablets, capsules, injectables, and advanced drug delivery systems
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

CDMO servicesFormulation development, process optimization, analytical support, and scalable manufacturing.
Source & evidence

Supplier website
Our comprehensive CDMO services include formulation development, process optimization, analytical support, and scalable manufacturing
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

cGMP Peptide ManufacturingPeptide manufacturing from pre-clinical and clinical batches through commercial-scale supply.
Source & evidence

Supplier website
Our cGMP-compliant peptide manufacturing infrastructure is designed for flexibility, scalability, and regulatory readiness across every phase of drug development
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Custom developmentRoute scouting, process optimization, formulation development, and pilot-scale manufacturing.
Source & evidence

Supplier website
Leveraging advanced R&D and GMP-certified facilities, we support every stage — from route scouting and process optimization to formulation development and pilot-scale manufacturing.
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Process developmentDevelopment of NCE APIs across clinical phases, including IND-enabling toxicology batches.
Source & evidence

Supplier website
With an accumulated knowledge of more than 30 years, dealing with various chemistries, we meticulously plan experiments with a prime focus on Process design, development and delivery of NCE API across all clinical phases including IND enabling Tox batch.
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Analytical DevelopmentAnalytical method development using RP-HPLC, LC-MS, and peptide mapping.
Source & evidence

Supplier website
DoE-driven optimization, impurity profiling, QbD implementation, analytical method development (RP-HPLC, LC-MS, peptide mapping).
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Analytical servicesAnalytical services are among the company's stated areas of expertise.
Source & evidence

Supplier website
With expertise across small molecules, peptides, HPAPIs, ADC linkers, specialty chemicals, polymers, and analytical services
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Standards QualificationQualification of impurity and reference or working standards.
Source & evidence

Supplier website
Standards Qualification › Impurities standard qualification › Reference / Working standard qualifications
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Industries served

Certificates & patents

Credential

US FDA Approved

United States Food & Drug Administration

Source & evidence

Supplier website
US FDA Approved (United States Food & Drug Administration)
Shilpa Pharma Lifesciences Limited website
Checked 24 Oct 2026

Evidence & freshness

Every claim keeps its source. Company-reported information and independent verification are labelled separately. Spot something wrong? .

  • Shilpa Pharma Lifesciences Limited websiteSupplier websiteChecked 24 Oct 2026

    Supports 25 facts: Company name · Description · Semaglutide · Octreotide Acetate · Bivalirudin · Tirzepatide · Leuprolide Acetate · Desmopressin Acetate

    17 more

    Liraglutide · Goserelin Acetate · Teriparatide · Dulaglutide · Lanreotide · Glucagon · Exenatide · Triptorelin · Atosiban · Advanced Peptide Modification and Conjugation Chemistry · Peptide Process Development · Regulatory Documentation and Filing Support · Peptide Synthesis Technologies · cGMP Peptide Manufacturing · Analytical Development · Location: Raichur, India · Location: address

  • Shilpa Pharma Lifesciences Limited websiteSupplier websiteChecked 24 Oct 2026

    Supports 20 facts: Company name · Description · SN-38 · Exatecan · DM1 · DM4 · MMAE · MMAF

    12 more

    Exatecan Mesylate · Irinotecan · Topotecan · MC-Val-Cit-PAB-Exatecan · Mc-VC-PAB-SN38 · DM1-SMCC · VcMMAE (MC-Val-Cit-PAB-MMAE) · ADC payload development support · Analytical development and process optimization · Custom ADC payload co-development and manufacturing · ADC payload manufacturing and bulk supply · Location: Raichur, India

  • Shilpa Pharma Lifesciences Limited websiteSupplier websiteChecked 24 Oct 2026

    Supports 15 facts: Company name · Description · Biologics manufacturing · Formulation development · CDMO services · Custom development · US FDA Approved · EU GMP Certified

    7 more

    ANVISA Approved · COFEPRIS Approved · TGA Certified · PMDA Approved · KFDA Certified · Location: Raichur, India · Location: address

  • Shilpa Pharma Lifesciences Limited websiteSupplier websiteChecked 24 Oct 2026

    Supports 13 facts: Company name · Description · Analytical Method Development & Validation · Analytical Testing · Photo-Stability & Forced Degradation Study · Impurity Evaluation & Impurity Profiling · Polymorph Profiling · Cleaning Method

    5 more

    Structure Elucidation · Stability Studies · Standards Qualification · Location: Raichur, India · Location: address

  • Shilpa Pharma Lifesciences Limited websiteSupplier websiteChecked 24 Oct 2026

    Supports 8 facts: Company name · Analytical and quality control services · Peptide CDMO · Pharmaceutical manufacturing · Process safety · Process development · Location: Raichur, India · Location: address

  • electronica 2026 exhibitor directoryTrade-fair listingChecked 26 Sept 2026

    Supports 7 facts: Company name · Description · Process chemicals & gases · Solder, adhesives & tapes · Consumer electronics · Power electronics & energy · Location: Raichur, India

  • Shilpa Pharma Lifesciences Limited websiteSupplier websiteChecked 24 Oct 2026

    Supports 6 facts: Company name · Description · Route scouting, process development, scale-up, and commercial supply · Analytical services · Location: Raichur, India · Location: address

  • Shilpa Pharma Lifesciences Limited websiteSupplier websiteChecked 24 Oct 2026

    Supports 3 facts: Company name · Description · Location: Raichur, India

What to confirm

A starting point for your supplier conversation.

Manufacturing processesNo source confirms this yet
Services and capabilitiesNo source confirms this yet
CertificationsNo source confirms this yet
Order quantity & lead timeConfirm directly with the supplier

Get in touch

Company contactkiran.sabale@shilpapharma.com
Contact sources

electronica 2026 exhibitor directory · 26 Sept 2026

Business type

AI interpretation; these are estimates, not verification.

Manufacturer · 93%
Source & evidence

AI-inferred
Based only on `company`, does this company manufacture its own products (it produces them itself or in its own/controlled factories)?

Is this your company?

Manage products, locations and the facts buyers and agents can retrieve.

Claim this profile Free. A work email on the company’s domain confirms it instantly.

Is something on this profile wrong or out of date?

Answers grounded in company sources

AI can make mistakes. Check sources and confirm requirements with the supplier.